MEDA

Last updated
MEDA
MEDA.png
Clinical data
Other names3-Methoxy-4,5-ethylenedioxyamphetamine; 5-Methoxy-3,4-ethylenedioxyamphetamine; 5-Methoxy-EDA; 5-MeO-EDA
Routes of
administration
Oral [1]
ATC code
  • None
Pharmacokinetic data
Duration of action Unknown [1]
Identifiers
  • 1-(8-methoxy-2,3-dihydro-1,4-benzodioxin-6-yl)propan-2-amine
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
Chemical and physical data
Formula C12H17NO3
Molar mass 223.272 g·mol−1
3D model (JSmol)
  • NC(CC1=CC2=C(OCCO2)C(OC)=C1)C
  • InChI=1S/C12H17NO3/c1-8(13)5-9-6-10(14-2)12-11(7-9)15-3-4-16-12/h6-8H,3-5,13H2,1-2H3 X mark.svgN
  • Key:NRVFDGZJTPCULU-UHFFFAOYSA-N Yes check.svgY
 X mark.svgNYes check.svgY  (what is this?)    (verify)

MEDA, also known as 3-methoxy-4,5-ethylenedioxyamphetamine or as 5-methoxy-EDA, is a chemical compound of the phenethylamine, amphetamine, and EDxx families. [1] [2] It is the EDxx analogue of MMDA (5-methoxy-MDA). [1] [2] [3] The compound was first synthesized by Alexander Shulgin. [1] [2] In his book PiHKAL , the minimum dose is listed as 200 mg, and the duration as unknown. [1] [2] MEDA produced few to no effects. [1] [2] Very little data exists about the pharmacological properties, metabolism, and toxicity of MEDA. [1] [2] MEDA was first described in the scientific literature by Shulgin in 1964. [3] [1] [2]

Contents

See also

References

  1. 1 2 3 4 5 6 7 8 9 MEDA entry in PiHKAL
  2. 1 2 3 4 5 6 7 Shulgin AT (2003). "Basic Pharmacology and Effects". In Laing RR (ed.). Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137. ISBN   978-0-12-433951-4. Archived from the original on 13 July 2025.
  3. 1 2 Shulgin AT (March 1964). "3-Methoxy-4,5-methylenedioxy Amphetamine, a New Psychotomimetic Agent". Nature. 201 (4924): 1120–1121. Bibcode:1964Natur.201.1120S. doi:10.1038/2011120a0. PMID   14152788. Archived from the original on 2025-07-12.